Clinical trials
Phase 3 COVID-19 trials in Peru
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2020 | 6 |
| 2021 | 5 |
| 2022 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Terminated | 4 |
| Recruiting | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| Merck Sharp & Dohme LLC | 2 |
| Universidad Peruana Cayetano Heredia | 2 |
| University of Minnesota | 2 |
| Corvus Pharmaceuticals, Inc. | 1 |
| Daniel Benjamin | 1 |
| Fulcrum Therapeutics | 1 |
| Genova Inc. | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 16 |
| Coronavirus Infections | 2 |
| Cardiovascular Diseases | 1 |
| Cytokine Release Syndrome | 1 |
| Infections | 1 |
| Inflammation | 1 |
| Influenza, Human | 1 |
| Lung Diseases | 1 |
| Myocardial Infarction | 1 |
| Respiratory Distress Syndrome | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.